$JANX

Janux Therapeutics, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA

JANX chart

What traders are saying about $JANX

Latest posts

Janux Therapeutics, Inc. news

Janux Therapeutics, Inc. key financials

USD2025202420232022
Net income-$113.6M-$69.0M-$58.3M-$63.1M
Diluted EPS$-1.83$-1.28$-1.32$-1.52
Total assets (year end)$1.00B$1.06B$380.4M$364.0M
Cash and equivalents (year end)$52.3M$430.6M$19.2M$51.4M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Janux Therapeutics, Inc.

Ticker
JANX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1817713

Frequently asked questions

What exchange is Janux Therapeutics, Inc. listed on?

Janux Therapeutics, Inc. trades on the Nasdaq under the ticker symbol JANX.

What industry is Janux Therapeutics, Inc. in?

Janux Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Janux Therapeutics, Inc. headquartered?

Janux Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.

When does Janux Therapeutics, Inc.'s fiscal year end?

Janux Therapeutics, Inc.'s fiscal year ends on December 31.